Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 12226 - 12250 of 14534 in total
Gisadenafil has been investigated for the treatment of Prostatic Hyperplasia.
Investigational
N-acetylmannosamine is under investigation for the other of GNE Myopathy.
Investigational
Olitigaltin has been investigated for the treatment of Idiopathic Pulmonary Fibrosis.
Investigational
CPX has been used in trials studying the treatment of Cystic Fibrosis.
Investigational
Telatinib is under investigation in clinical trial NCT03817411 (Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ Cancer).
Investigational
Experimental
β-Methylfentanyl is an analgesic of the opioid class. It is an analog of the potent opioid, fentanyl.
Illicit
Butyrfentanyl or butyrylfentanyl (not to be confused with 3-methylfentanyl) is a potent short-acting synthetic opioid analgesic drug. It is an analog of fentanyl with roughly 1/30 the potency. Butyrfentanyl was first synthesized in 1961 by Janssen Pharmaceuticals as a new opioid analgesic. Butyrfentanyl has no current legitimate clinical applications, but...
Illicit
Displaying drugs 12226 - 12250 of 14534 in total